Skip to content

The Study of Glycemic Index of NEO-MUNE

The Study of Glycemic Index of NEO-MUNE

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20170906002
Enrollment
Unknown
Registered
2017-09-06
Start date
2016-10-18
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glycemic index of NEO&#45

Interventions

Mune is the medical food for patients who need high protein and high calories
Experimental Other
MUNE

Sponsors

Thai Otsuka Pharmaceutical Co., Ltd.
Lead Sponsor
Thai Otsuka Pharmaceutical Co.&#44
Collaborator
Ltd.
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.18 years of age as the minimum age 2.Body Mass Index in the range of 18.5 - 24.9 kg/m2 3.Do not have any underlying disease 4.Do not have a family history of diabetes 5.Do not have any allergy of any component in the formula such as protein in cow milk, Glutamine, Arginine, fish oil etc. 6.Consent to participate the study and sign in the consent form with the understanding of detail and be able to follow the process

Exclusion criteria

Exclusion criteria: 1.Having underlying disease such as diabetes, hypertension, heart and vascular disease, hepatic disease, kidney disease and disease which affect the metabolism such as thyroid disease etc. 2.Having medication, dietary supplement and vitamin within 7 days prior to the study 3.Pregnant or breastfeeding subject 4.Unable to follow the study process

Design outcomes

Primary

MeasureTime frame
Low glycemic index 0, 30, 60, 90, 120 minutes AUC of blood glucose

Secondary

MeasureTime frame
N/A N/A N/A

Countries

Thailand

Contacts

Public ContactSupawan Buranapin

Faculty of Medicine, Chiangmai University

supawan.b@cmu.ac.th053-936-453

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026